19 Jun 2018

Roche bags full ownership of Foundation Medicine in $2.4B follow-up buyout

Amber Tong

ENDPTS

19 Jun 2018

Biogen plunges after rival drug for spinal muscular atrophy shows promise

Chloe Aiello

CNBC

19 Jun 2018

FDA rejects Duobrii, a Valeant `Significant Seven` drug

Angus Liu

FIERCE PHARMA

19 Jun 2018

Celltrion returns to FDA with Herceptin biosimilar candidate

Eric Palmer

FIERCE PHARMA

19 Jun 2018

Ziopharm hit with clinical hold as FDA red lights POC study on CAR-T

John Carroll

ENDPTS

19 Jun 2018

Veteran analyst Eric Schmidt moves over to biotech Allogene

Amirah Al Idrus

FIERCE BIOTECH

19 Jun 2018

AbbVie unveils high undetectable disease rates for venetoclax/rituximab combo

Selina McKee

PHARMA TIMES

19 Jun 2018

Merck, Novartis and more make the Lions Health shortlist

Tracy Staton

FIERCE PHARMA

18 Jun 2018

US needs to invest `tens of billions or hundreds of billions`

CNBC

18 Jun 2018

FDA Issues Guidance on Drugs to Treat Epidermolysis Bullosa

Michael Mezher

RAPS

PharmaCompass >>